Integra Lifesciences Holdings (IART) Tops Q3 EPS by 2c
Integra Lifesciences Holdings (NASDAQ: IART) reported Q3 EPS of $0.72, $0.02 better than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
